Novita Pharmaceuticals, Inc.
3 clinical trials · Sponsor
◉ Watch Novita Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| Trial of NP-G2-044 (Prilukae) Combined With PLD for Treatment of Platinum-Resistant Ovarian Cancer (ULTIMUS-1) (NCT07109414) | Novita Pharmaceuticals, Inc. | 2025-12-29 |
| NP-G2-044 as Monotherapy and Combination Therapy in Patients With Advanced or Metastatic Solid Tumor Malignancies (NCT05023486) | Novita Pharmaceuticals, Inc. | 2021-12-07 |
| Clinical Trial of Metastasis Inhibitor NP-G2-044 in Patients With Advanced or Metastatic Treatment-Refractory Solid Tumor Malignancies (NCT03199586) | Novita Pharmaceuticals, Inc. | 2017-12-21 |
Track Novita Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.